Compared with the present nucleotide drugs that act on HBV DNA synthesis, the inhibitory peptides in this invention can inhibit the duplication of HBV.
实验证明了本发明所筛选的三种抑制肽对HBV的DNA有明显的抑制作用，为抗hbv药物的制备提供了一种新的有效的药源。
So analogs, including nucleoside and nucleotide analogs are now potent drugs, which suppress complicated viral replication of HVC, I will say in 70% to 90% of the patients.
因此，现在核苷类药物是强效药物，能抑制复杂的丙肝病毒复制，我认为能抑制70%到90%的患者。
应用推荐